Head and Neck Cancer Trial, Recruiting NCT06148077 Sponsor: Universidad de La Frontera Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06148077
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with head and neck cancer
  • People who are 18 years of age or older
  • People who have had surgery and/or radiotherapy (radiation treatment) for head and neck cancer
  • People who finished their cancer treatment between 3 and 36 months before joining the trial
  • People who have a medical diagnosis of trismus (difficulty opening the mouth), jaw joint problems (TMD), and/or stiffness or dysfunction in the neck or shoulder
  • People whose first language is Spanish

Who may not be able to join:

  • People who have had a stroke in the past that left lasting effects
  • People with instability, osteoporosis (weak or fragile bones), bone degeneration, or herniated discs in the neck
  • People who currently have bone damage caused by radiation (osteoradionecrosis) or open wounds such as fistulas or tissue breakdown in the area to be treated
  • People who have a tracheostomy (a breathing tube in the throat)
  • People who have cancer that has spread to other parts of the body, or whose cancer is still active
  • People who do not wish to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Barbara Burgos, PhD, Universidad de La Frontera

Phone: +56991358814

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad de La Frontera
Registry
ClinicalTrials.gov
Start date
25 September 2024
Est. completion
1 October 2025

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Maximal mouth opening (MMO); Temporomandibular disorders (TMD); Swallowing function; Swallowing difficulty; Dysphagia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov